Psychological Impact of Melanoma, How to Detect, Support and Help

  • Aleksandra Vojvodic Department of Dermatology and Venereology, Military Medical Academy, Belgrade, Serbia
  • Tatjana Vlaskovic-Jovicevic Clinic for Psychiatric Disorders “Dr. Laza Lazarevic”, Belgrade, Serbia
  • Petar Vojvodic Clinic for Psychiatric Disorders “Dr. Laza Lazarevic”, Belgrade, Serbia
  • Jovana Vojvodic Clinic for Psychiatric Disorders “Dr. Laza Lazarevic”, Belgrade, Serbia
  • Mohamad Goldust Guglielmo Marconi University, Rome, Italy
  • Zorica Peric-Hajzler Military Medical Academy, Belgrade, Serbia
  • Dusica Matovic Military Medical Academy, Belgrade, Serbia
  • Goran Sijan Clinic for Plastic Surgery and Burns, Military Medical Academy, Belgrade, Serbia
  • Nenad Stepic Clinic for Plastic Surgery and Burns, Military Medical Academy, Belgrade, Serbia
  • Van Thuong Nguyen Vietnam National Hospital of Dermatology and Venereology, Hanoi, Vietnam
  • MIchael Tirant G. Marconi University, Rome, Italy
  • Uwe Wollina Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Dresden, Germany
  • Torello Lotti University of Rome G. Marconi, Rome, Italia
  • Massimo Fioranelli Department of Nuclear Physics, sub-nuclear and radiation, G. Marconi University, Rome, Italy
Keywords: melanoma, psychology, depression, anxiety

Abstract

Incidence of melanoma is increasing every year. A few years ago, we could not speak about long term survivors with melanoma. Chemotherapy did not give a good effect in the past. Metastasis occurred very rapidly, and the progression of melanoma was very fast. But now, with new forms of therapy, especially immunotherapy and target therapy, for the first time, we have long-time survivors. For the prognosis of melanoma, the most important is the stage in which melanoma is detected. For all dermatologists, it is very important to be aware of the psychological impact of melanoma on patients. Dermatologists should recognise psychological disorders. Several different scales can be used for the detection of depression and anxiety – some of them are completed by researchers, some of them are completed by patients, and also, we have combined scales. The need for adequate social and family support as well as psychological help to achieve better coping with illness is necessary. Learning techniques to overcome fear and stress would help in better functioning of all affected, regardless of the stage of the disease. The most severe cases of anxiety and depression, in addition to psychotherapeutic interventions, should also be considered medication therapy.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

Author Biography

Torello Lotti, University of Rome G. Marconi, Rome, Italia

Prof. Lotti is Full Professor of the Dermatology and Venereology at University of Studies Guglielmo Marconi, Rome, Italy. He is Honorary Professor of Dermatology - China Medical University Shenyang (2011), Lecturer at the New York Academy of Sciences "Howard Fox Memorial Lecture" (14 March 2012 - New York, NY – USA), and Chair, Executive Scientific Committee Vitiligo Research Foundation, New York , NY , USA. He is President of the World Health Academy, Dermatology since 2013. He has been Full Professor of the Dermatology and Venereology Division at University of Florence School of Medicine, Florence, Italy, from 2006 to 2010. He is Visiting Professor in six International Universities worldwide, and Key Note Lecturer in several international dermatology Societies. His activities in serving Dermatology have been numerous: President of the Italian Society of Dermatology and Venereology (SIDeMaST , 2009-2010) and President of the International Society of Dermatology ( ISD, 2009-2010), President of the European Society for Cosmetic and Aesthetic Dermatology (2003-2004), Editor in Chief of the Journal of the European Academy of Dermatology and Venereology (1992-2002) , Editor "Therapeutic Hotline"- Dermatologic Therapy (2007-)and served as Editor in Chief of the Giornale Italiano di Dermatologia in the period of presidency of the Societa' Italiana di Dermatologia (2009-2010). He has been President of numerous international congresses and is currently Editor in Chief of the Giornale Italiano di Dermatologia e Venereologia ( 2010-2020 ). He is Ordinary Member of the main Scientific Societies worldwide (EADV, SIDEV , ESDR , ISD, AAD, SID) and Honorary Member of several Scientific Societies of the Dermatology field. Moreover, he is a Scientific reviewer of ten sectorial journals, among which are the British Journal of Dermatology, Journal of Investigative Dermatology, Journal of the American Academy of Dermatology , Dermatologic Therapy. He has authored 1054 scientific publications (393 peer reviewed articles, 288 books chapters e 365 abstracts). For more information, see www.torellolotti.it

References

Vojvodic A, Dedic G. Depression, anxiety and quality of life in patients with melanoma. VSP, 2018. https://doi.org/10.2298/VSP180414185V

Vojvodic A, Dedic G. Quality of Life and Anxiety in Military Personnel. SJECR, 2017.

Lotti T, Bruscino N, Hercogova J, de Giorgi V. Controversial issues on melanoma. Dermatol Ther. 2012; 25(5):458-62. https://doi.org/10.1111/j.1529-8019.2012.01524.x PMid:23046025

Campolmi E, et al. Melanoma diagnosis: traumatic impact of the event on the patient. G Ital Dermatol Venereol. 2019.

de Giorgi V, Gori A, Grazzini M, Rossari S, Scarfì F, Corciova S, Verdelli A, Lotti T, Massi D. Estrogens, estrogen receptors and melanoma. Expert Rev Anticancer Ther. 2011;11(5):739-47. https://doi.org/10.1586/era.11.42 PMid:21554049

De Giorgi V, Grazzini M, Gandini S, Benemei S, Lotti T, Marchionni N, Geppetti P. Treatment with β-blockers and reduced disease progression in patients with thick melanoma. Arch Intern Med. 2011; 171(8):779-81. https://doi.org/10.1001/archinternmed.2011.131 PMid:21518948

Rogiers A, Boekhout A, Schwarze JK, Awada G, Blank CU, Neyns B. Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors. J Oncol. 2019. https://doi.org/10.1155/2019/5269062 PMid:31182961 PMCid:PMC6512024

Heino PJ, Mylläri PH, Jahkola TA, Sintonen H, Luoma ML, Räsänen P, Roine RP. Long-Term Quality of Life of Melanoma Survivors Is Comparable to that of the General Population. Anticancer Res. 2019; 39(5):2633-2640. https://doi.org/10.21873/anticanres.13387 PMid:31092462

O'Reilly A, et al. An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors. Support Care Cancer. 2019. https://doi.org/10.1007/s00520-019-04818-w

Dieng M, et al. Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled Trial. J Clin Oncol. 2016; 34(36):4405-4414. https://doi.org/10.1200/JCO.2016.68.2278 PMid:27998215

Fioranelli M, Roccia MG, Pastore C, Aracena CJ, Lotti T. Completion dissection or observation for sentinel-node metastasis in melanoma. Dermatol Ther. 2017; 30(6). https://doi.org/10.1111/dth.12544 PMid:28836714

Vaccaro M, Lentini M, Lotti J, Fioranelli M, Roccia MG, Lotti T, Guarneri C. Hard to face: cutaneous malignant melanoma. J Biol Regul Homeost Agents. 2017; 31(2):53-55.

Chokoeva AA, Tchernev G, Wollina U, Lotti T. Cutaneous melanoma: how to improve the quality of diagnosis and treatment - a regional experience. Dermatol Ther. 2015; 28(6):344-5. https://doi.org/10.1111/dth.12278 PMid:26279288

Vojvodic A, Dedic G, Djukic-Dejanovic S. Defense mechanisms and quality of life in military personnel with burnout syndrome. VSP. 2019. 76(3):298-306. https://doi.org/10.2298/VSP170304114V

Smith K. Mental health: a world of depression. Nature. 2014; 515(7526):181. https://doi.org/10.1038/515180a PMid:25391942

Tas F, Karabulut S, Guveli H, Kurul S, Erturk K, Guveli M, Kinik H. Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients. Asian Pac J Cancer Prev. 2017; 18(2):369-373.

Brown SL, Hope-Stone L, Heimann H, Damato B, Salmon P. Predictors of anxiety and depression 2 years following treatment in uveal melanoma survivors. Psychooncology. 2018; 27(7):1727-1734. https://doi.org/10.1002/pon.4715 PMid:29601654

Miniati M, et al. Quality of Life, Depression, and Anxiety in Patients with Uveal Melanoma: A Review. J Oncol. 2018:5253109. https://doi.org/10.1155/2018/5253109 PMid:29755525 PMCid:PMC5883983

Published
2019-08-30
How to Cite
1.
Vojvodic A, Vlaskovic-Jovicevic T, Vojvodic P, Vojvodic J, Goldust M, Peric-Hajzler Z, Matovic D, Sijan G, Stepic N, Nguyen VT, Tirant M, Wollina U, Lotti T, Fioranelli M. Psychological Impact of Melanoma, How to Detect, Support and Help. Open Access Maced J Med Sci [Internet]. 2019Aug.30 [cited 2020Oct.26];7(18):3043-5. Available from: https://www.id-press.eu/mjms/article/view/oamjms.2019.770

Most read articles by the same author(s)

1 2 3 > >>